Lupus (SLE): nyitott vizsgálatok itt: Egyesült Királyság

19 nyitott vizsgálatnak van helyszíne itt: Egyesült Királyság. Regiszteradat; hogy ki vehet részt, azt csak a vizsgálat csapata dönti el.

NCT07332481
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease
Kísérleti kezelés · 3. fázis · EMD Serono Research & Development Institute, Inc.
Whipps Cross University Hospital - Dept of Rheumatology, London · Freeman Hospital - Dept of Rheumatology, Newcastle upon Tyne
Regiszter frissítve: 2026-11-04
NCT07355218
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)
Kísérleti kezelés · 3. fázis · EMD Serono Research & Development Institute, Inc.
Doncaster Royal Infirmary - Dept of Rheumatology, Doncaster · Guy's Hospital - Louise Coote Lupus Unit, London · Walsall Manor Hospital, Walsall
Regiszter frissítve: 2026-11-04
NCT05039619
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants
Kísérleti kezelés · 2. fázis · Hoffmann-La Roche
Royal Hospital for Children, Glasgow · Alder Hey Childrens Hospital, Liverpool · Great Ormond Street Hospital for Children, London
Regiszter frissítve: 2026-11-03
NCT07438496
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
Kísérleti kezelés · 3. fázis · Janssen Research & Development, LLC
Royal National Hospital for Rheumatic Diseases, Bath · Addenbrookes Hospital, Cambridge · Guy's and St Thomas' NHS Foundation Trust, Greater London · Newcastle Freeman Hospital, Newcastle upon Tyne · Peterborough City Hospital, Peterborough · Royal Berkshire Hospital, Reading · Southampton University Hospital, Southampton · Haywood Hospital, Stoke-on-Trent · Great Western Hospital, Swindon
Regiszter frissítve: 2026-11-03
NCT07913919
Effect of Anifrolumab on Arterial Inflammation in Systemic Lupus Erythematosus Study
Kísérleti kezelés · University of Cambridge
Addenbrookes Hospital, Cambridge
Regiszter frissítve: 2026-11-03
NCT06617325
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
Kísérleti kezelés · 3. fázis · UCB Biopharma SRL
Sl0044 40847, Bath · Sl0044 40858, Belfast · Sl0044 40281, Leeds · Sl0044 40113, London · Sl0044 40864, Newcastle upon Tyne · Sl0044 40701, Sheffield · Sl0044 40725, West Bromwich
Regiszter frissítve: 2026-11-02
NCT07175285
A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
Kutatás · Bristol-Myers Squibb
Royal National Hospital for Rheumatic Diseases-Bath, Bath · King's College Hospital NHS Foundation Trust, London · The Royal Free London NHS Foundation Trust - The Royal Free Hospital, London · Oxford University Hospitals NHS Trust - Churchill Hospital, Oxford · The Royal Wolverhampton NHS Trust - New Cross Hospital, Wolverhampton
Regiszter frissítve: 2026-11-02
NCT07053800
Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)
Kísérleti kezelés · 2. fázis · Autolus Limited
Queen Elizabeth Hospital Birmingham, Birmingham · Bristol Haematology and Oncology Centre, Bristol · Addenbrooke's Hospital, Cambridge · Western General Hospital Edinburgh, Edinburgh · Queen Elizabeth University Hospital, Glasgow · Great Ormond Street Hospital, London · University College Hospital, London · Manchester Royal Infirmary, Manchester
Regiszter frissítve: 2026-10-30
NCT07201558
Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
Kísérleti kezelés · 1. fázis · AstraZeneca
London
Regiszter frissítve: 2026-10-28
NCT07409181
A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
Kísérleti kezelés · 2. fázis · Boehringer Ingelheim
Basingstoke and North Hampshire Hospital, Basingstoke · Belfast City Hospital, Belfast · Addenbrooke's Hospital, Cambridge · Doncaster Royal Infirmary, Doncaster
Regiszter frissítve: 2026-10-28
NCT07691970
Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued Treatment
Kísérleti kezelés · 3. fázis · AstraZeneca
Cambridge · Leeds · London · Newcastle upon Tyne · Sheffield
Regiszter frissítve: 2026-10-28
NCT06916806
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
Kísérleti kezelés · 1. fázis · AstraZeneca
Glasgow · London · Southampton
Regiszter frissítve: 2026-10-19
NCT05352919
A Study to Learn More About the Long-Term Safety of Litifilimab (BIIB059) Injections and it's Effects on Symptoms in Adults With Systemic Lupus Erythematosus (SLE)
Kísérleti kezelés · 3. fázis · Biogen
Cannock Chase Hospital, Cannock · Doncaster Royal Infirmary, Doncaster · Guy's Hospital, London
Regiszter frissítve: 2026-10-05
NCT06570798
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
Kísérleti kezelés · 2. fázis · Amgen
Addenbrookes Hospital, Cambridge · Western General Hospital, Edinburgh · Leicester General Hospital, Leicester · Royal Victoria Infirmary, Newcastle upon Tyne
Regiszter frissítve: 2026-10-05
NCT05835310
An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
Kísérleti kezelés · 3. fázis · AstraZeneca
Birmingham · Bristol · Liverpool · London · Manchester · Southampton
Regiszter frissítve: 2026-09-30
NCT06897930
A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
Kísérleti kezelés · 1/2. fázis · AstraZeneca
Bristol
Regiszter frissítve: 2026-09-10
NCT06576271
A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and Japanese Participants and CTD-ILD Participants
Kísérleti kezelés · 1. fázis · GlaxoSmithKline
Cambridge · Liverpool · London · Middlesex
Regiszter frissítve: 2026-06-22
NCT06308978
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
Kísérleti kezelés · 1. fázis · Fate Therapeutics
Cambridge University Hospitals NHS Foundation Trust, Cambridge · University College of London Hospitals NHS Trust (UCLH), London · Manchester University NHS Foundation Trust, Manchester
Regiszter frissítve: 2026-05-22
NCT00198068
Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)
Kutatás · Hospital for Special Surgery, New York
Ez a vizsgálat csak várandós résztvevőket keres
Guy's & St Thomas' NHS Foundation Trust, London
Regiszter frissítve: 2026-04-28

Minden vizsgálat (Lupus (SLE)) és a térkép

Ez az oldal nem orvosi tanács. Mielőtt egy vizsgálatot megkeresel, beszélj az orvosoddal.

Hibát jelzek